These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2000700)

  • 1. The thyroid hormone analogue SKF-94901 and iodothyronine binding sites in mammalian tissues: differences in cytoplasmic binding between liver and heart.
    Barlow JW; Raggatt LE; Lim CF; Kolliniatis E; Topliss DJ; Stockigt JR
    Acta Endocrinol (Copenh); 1991 Jan; 124(1):37-44. PubMed ID: 2000700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thyroid hormone analogue SKF L-94901: nuclear occupancy and serum binding studies.
    Barlow JW; Raggatt LE; Lim CF; Munro SL; Topliss DJ; Stockigt JR
    Clin Sci (Lond); 1989 May; 76(5):495-501. PubMed ID: 2721116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of reverse T3 to hepatic nuclear protein.
    Smith HC; Robinson SE; Eastman CJ
    Aust J Exp Biol Med Sci; 1980 Apr; 58(2):207-12. PubMed ID: 7436879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells.
    Samuels HH; Tsai JS; Casanova J; Stanley F
    J Clin Invest; 1974 Oct; 54(4):853-65. PubMed ID: 4372251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity thyroid hormone-binding protein in human kidney: kinetic characterization and identification by photoaffinity labeling.
    Vié MP; Blanchet P; Samson M; Francon J; Blondeau JP
    Endocrinology; 1996 Nov; 137(11):4563-70. PubMed ID: 8895318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific transport of triiodothyronine from plasma to cytosol and from cytosol to nucleus in rat liver, kidney, brain, and heart.
    Oppenheimer JH; Schwartz HL
    J Clin Invest; 1985 Jan; 75(1):147-54. PubMed ID: 3965501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific nuclear binding sites of triiodothyronine and reverse triiodothyronine in rat and pork liver: similarities and discrepancies.
    Wiersinga WM; Chopra IJ; Solomon DH
    Endocrinology; 1982 Jun; 110(6):2052-8. PubMed ID: 7075548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cytoplasmic T3 binding sites by adsorption to hydroxyapatite: effects of drug inhibitors of T3 and relationship to glutathione-S-transferases.
    Barlow JW; Raggatt LE; Lim CF; Topliss DJ; Stockigt JR
    Thyroid; 1992; 2(1):39-44. PubMed ID: 1326362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro binding of L-triiodothyronine to receptors in rat liver nuclei. Kinectics of binding, extraction properties, and lack of requirement for cytosol proteins.
    Surks MI; Koerner DH; Oppenheimer JH
    J Clin Invest; 1975 Jan; 55(1):50-60. PubMed ID: 162784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear thyroid hormone receptor in the rat uterus.
    Evans RW; Farwell AP; Braverman LE
    Endocrinology; 1983 Oct; 113(4):1459-63. PubMed ID: 6311523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity.
    Underwood AH; Emmett JC; Ellis D; Flynn SB; Leeson PD; Benson GM; Novelli R; Pearce NJ; Shah VP
    Nature; 1986 Dec 4-10; 324(6096):425-9. PubMed ID: 3785422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of thyroid hormones to nuclear extracts of thyroid cells.
    Erkenbrack DE; Rosenberg LL
    Endocrinology; 1986 Jul; 119(1):311-7. PubMed ID: 3013592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of rat liver nuclear thyroid hormone receptors.
    Ichikawa K; DeGroot LJ
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3420-4. PubMed ID: 3472213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and metabolism of L- and D-triiodothyronine (T3) in the rat: preferential accumulation of L-T3 by hepatic and cardiac nuclei as a probable explanation of the differential biological potency of T3 enantiomers.
    Schwartz HL; Trence D; Oppenheimer JH; Jiang NS; Jump DB
    Endocrinology; 1983 Oct; 113(4):1236-43. PubMed ID: 6617571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug competition for intracellular triiodothyronine-binding sites.
    Barlow JW; Curtis AJ; Raggatt LE; Loidl NM; Topliss DJ; Stockigt JR
    Eur J Endocrinol; 1994 Apr; 130(4):417-21. PubMed ID: 8162174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone binding to plasma membrane preparations: studies in different thyroid states and tissues.
    Gharbi-Chihi J; Torresani J
    J Endocrinol Invest; 1981; 4(2):177-83. PubMed ID: 6268692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of nuclear 3,5,3'-triiodothyronine-binding sites in fetal human lung.
    Gonzales LW; Ballard PL
    J Clin Endocrinol Metab; 1981 Jul; 53(1):21-8. PubMed ID: 6263937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple thyroid hormone binding sites on male rat liver nuclear matrices.
    Venkatraman JT; Lefebvre Y
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1496-502. PubMed ID: 3318835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential inhibition of cytoplasmic T3 binding is associated with reduced nuclear binding in cultured cells.
    Barlow JW; Raggatt LE; Scholz GH; Loidl NM; Blok RB; Topliss DJ; Stockigt JR
    Thyroid; 1996 Feb; 6(1):47-51. PubMed ID: 8777384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone analogues. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart.
    Leeson PD; Ellis D; Emmett JC; Shah VP; Showell GA; Underwood AH
    J Med Chem; 1988 Jan; 31(1):37-54. PubMed ID: 3336030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.